NCT01081743

Brief Summary

Context: The French Alzheimer plan 2008-2012 includes the implementation of "disease managers" or social workers, from the onset of the disease, for every patient with a diagnosis of Alzheimer disease or associated disorder. However, previous trials evaluating the efficacy of a systematic intervention for each case from the onset of the disease, including non complex cases, have shown little evidence. Objective: To evaluate the efficacy of a social worker to prevent behavioural problem for patient with a new diagnosis of Alzheimer disease or associated disorder. Design and setting: Multicentric cluster randomized control trial. Patients from several memory consultations and specialists (neurologist, psychiatrist or geriatrician) in France are included. Intervention: In addition to usual care, patients in the intervention group have systematic home visits from a social worker and regular follow-ups by phone over a one-year period. This social worker informs the patient and caregiver, evaluates the needs, gives advices to prevent complications and is a link between the patient and the memory consultation or the specialist. Patient in the control group have absolutely no intervention and are followed-up as usually. In order to not modify the usual care, they have no information on their participation in this trial before the one-year evaluation. Main outcome measure: NeuroPsychiatric Inventory (NPI) administrated at one year, which evaluates frequency, severity and repercussion of several behavioural problems. Secondary outcomes included disability, cognition, depression, health, quality of life, institutionalization, and resource use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 24, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 5, 2010

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2013

Completed
Last Updated

August 28, 2017

Status Verified

August 1, 2017

Enrollment Period

3.9 years

First QC Date

March 4, 2010

Last Update Submit

August 25, 2017

Conditions

Keywords

AlzheimerDementiaMild to moderately severeNew diagnosisPrevention of behavioural problems

Outcome Measures

Primary Outcomes (1)

  • NeuroPsychiatric Inventory (NPI)

    Evaluation of frequency, severity and repercussion of several behavioural problems

    1 year

Secondary Outcomes (12)

  • Cohen-Mansfield Agitation Inventory (CMAI)

    1 year

  • Apathy Inventory

    1 year

  • Disablement Assessment for Dementia (DAD)

    1 year

  • Mini Mental State Examination (MMSE)

    1 year

  • Global Deterioration Scale (GDS)

    1 year

  • +7 more secondary outcomes

Study Arms (2)

Social worker

EXPERIMENTAL
Other: Intervention of the social worker

Control

NO INTERVENTION

Control group is followed-up as usually (usual care)

Interventions

Systematic home visits and regular follow-ups by phone from a social worker

Social worker

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Alzheimer's Disease or other dementia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition \[DSM IV\] criteria of dementia)
  • Presence of an informal caregiver
  • Mild to moderately severe dementia (MMSE \[10-28\])
  • Diagnosis of dementia made by a specialist ≤ 6 months
  • Patient affiliated to the national health insurance system

You may not qualify if:

  • Institutionalized patient
  • Patient on legal guardianship
  • Behavioural problem with important clinical repercussion
  • Psychotic syndrome
  • Severe and unstable general pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ISPED (Institut de Santé Publique, d'Epidémiologie et de Développement)

Bordeaux, 33076, France

Location

MeSH Terms

Conditions

Alzheimer DiseaseDementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2010

First Posted

March 5, 2010

Study Start

November 24, 2009

Primary Completion

October 2, 2013

Study Completion

October 2, 2013

Last Updated

August 28, 2017

Record last verified: 2017-08

Locations